Literature DB >> 33026492

Autoimmune encephalitis with psychiatric features in adults: historical evolution and prospective challenge.

Niels Hansen1, Charles Timäus2.   

Abstract

Our review aims to delineate the psychiatric spectrum of autoantibody-associated autoimmune encephalitis over time through its discoveries of antibodies. We searched in PubMed for appropriate articles depicting the first appearance and spectrum of psychiatric symptomatology in autoantibody-positive encephalitis for this narrative review. Memory impairment was first associated with autoantibodies against intracellular antigens such as anti-HuD antibodies in 1993. 8 years later, autoantibodies against cell membrane surface antigens such as voltage-gated potassium channels were described in conjunction with memory dysfunction. The spectrum of psychiatric syndromes was amplified between 1990 and 2020 to include disorientation, behavior, cognitive dysfunction, obsessive compulsive behavior and suicidality in encephalitis patients occurring together mainly with antibodies against surface antigens, less so against intracellular antigens. In general, we found no specific psychiatric symptoms underlying specific autoantibody-associated encephalitis. As fundamental data on this issue have not been systemically assessed to date, we cannot know whether our specific findings would remain from systematic studies, i.e., on the association between cerebrospinal fluid N-methyl-D-aspartate receptor antibodies in catatonia. The psychiatric symptomatology overlaps between psychiatric domains and occurs frequently in antibody-positive encephalitis. No specific psychiatric symptoms imply an underlying, specifically autoantibody-associated encephalitis. The psychiatric phenotypology associated with antibody-positive encephalitis has evolved tremendously recently, and this new evidence reveals its relevance for future diagnostic and treatment aspects of autoimmune encephalitis patients.

Entities:  

Keywords:  Autoantibodies; Autoimmune encephalitis; Intracellular antibodies; Membrane surface antibodies; Psychiatry

Mesh:

Substances:

Year:  2020        PMID: 33026492      PMCID: PMC7815593          DOI: 10.1007/s00702-020-02258-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  86 in total

Review 1.  Identification of adenylate kinase 5 antibodies during routine diagnostics in a tissue-based assay: Three new cases and a review of the literature.

Authors:  Corinna I Bien; Ferdinand Nehls; Rainer Kollmar; Maria Weis; Wolfgang Steinke; Friedrich Woermann; Josep Dalmau; Christian G Bien
Journal:  J Neuroimmunol       Date:  2019-05-29       Impact factor: 3.478

2.  "Limbic encephalitis" and its association with carcinoma.

Authors:  J A Corsellis; G J Goldberg; A R Norton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

3.  Potassium channel antibodies in two patients with reversible limbic encephalitis.

Authors:  C Buckley; J Oger; L Clover; E Tüzün; K Carpenter; M Jackson; A Vincent
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

Review 4.  Thyroid autoimmunity in bipolar disorder: A systematic review.

Authors:  Margherita Barbuti; André F Carvalho; Cristiano A Köhler; Andrea Murru; Norma Verdolini; Giovanni Guiso; Ludovic Samalin; Michael Maes; Brendon Stubbs; Giulio Perugi; Eduard Vieta; Isabella Pacchiarotti
Journal:  J Affect Disord       Date:  2017-06-13       Impact factor: 4.839

5.  Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Authors:  Anna Boronat; Jeffrey M Gelfand; Nuria Gresa-Arribas; Hyo-Young Jeong; Michael Walsh; Kirk Roberts; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Bernardo Rudy; Josep Dalmau
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

6.  A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder.

Authors:  Chi-Un Choe; Evangelos Karamatskos; Benjamin Schattling; Frank Leypoldt; Gianpiero Liuzzi; Christian Gerloff; Manuel A Friese; Christoph Mulert
Journal:  Psychiatry Res       Date:  2012-12-13       Impact factor: 3.222

7.  Expression of the onconeural CV2/CRMP5 antigen in thymus and thymoma.

Authors:  Jean-Philippe Camdessanché; François Lassablière; David Meyronnet; Karine Férraud; Léna Absi; Jérôme Honnorat; Jean-Christophe Antoine
Journal:  J Neuroimmunol       Date:  2006-03-07       Impact factor: 3.478

8.  Effect of LGI1 antibody-positive IgG on hippocampal neuron survival: a preliminary study.

Authors:  Neşe Ayşit-Altuncu; Canan Ulusoy; Gürkan Öztürk; Erdem Tüzün
Journal:  Neuroreport       Date:  2018-08-01       Impact factor: 1.837

9.  The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.

Authors:  Adam Al-Diwani; Adam Handel; Leigh Townsend; Thomas Pollak; M Isabel Leite; Paul J Harrison; Belinda R Lennox; David Okai; Sanjay G Manohar; Sarosh R Irani
Journal:  Lancet Psychiatry       Date:  2019-02-11       Impact factor: 27.083

10.  Persistent anterograde amnesia following limbic encephalitis associated with antibodies to the voltage-gated potassium channel complex.

Authors:  Christopher R Butler; Thomas D Miller; Manveer S Kaur; Ian W Baker; Georgie D Boothroyd; Nathan A Illman; Clive R Rosenthal; Angela Vincent; Camilla J Buckley
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-01-08       Impact factor: 10.154

View more
  3 in total

1.  Prevalence of Anti-neural Autoantibodies in a Psychiatric Patient Cohort-Paradigmatic Application of Criteria for Autoimmune-Based Psychiatric Syndromes.

Authors:  Niels Hansen; Aaron Levin Juhl; Insa Maria Grenzer; Kristin Rentzsch; Jens Wiltfang; Dirk Fitzner
Journal:  Front Psychiatry       Date:  2022-05-30       Impact factor: 5.435

2.  Autoimmune Encephalitis Presenting as Dystonia-Parkinsonism.

Authors:  Sophia E Milburn; Colin Van Hook; Andrew J Steven
Journal:  Ochsner J       Date:  2022

3.  Clinical Features and Early Recognition of 242 Cases of Autoimmune Encephalitis.

Authors:  Mu Yang; Yajun Lian
Journal:  Front Neurol       Date:  2022-01-13       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.